Cargando…

Resistance mechanisms and molecular epidemiology of carbapenem-nonsusceptible Escherichia coli in Taiwan, 2012-2015

PURPOSE: This study aimed to investigate the resistance mechanisms and molecular epidemiology of carbapenem-nonsusceptible Escherichia coli (CnsEC) in Taiwan. PATIENTS AND METHODS: From 2012 to 2015, 237 E. coli isolates with minimum inhibitory concentrations of imipenem or meropenem >1 μg/mL wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Ya-Ting, Siu, L Kristopher, Wang, Jann-Tay, Wu, Tsu-Lan, Chen, Yu-Hui, Chuang, Yin-Ching, Lin, Jung-Chung, Lu, Po-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642643/
https://www.ncbi.nlm.nih.gov/pubmed/31406467
http://dx.doi.org/10.2147/IDR.S208231
_version_ 1783437016649695232
author Chang, Ya-Ting
Siu, L Kristopher
Wang, Jann-Tay
Wu, Tsu-Lan
Chen, Yu-Hui
Chuang, Yin-Ching
Lin, Jung-Chung
Lu, Po-Liang
author_facet Chang, Ya-Ting
Siu, L Kristopher
Wang, Jann-Tay
Wu, Tsu-Lan
Chen, Yu-Hui
Chuang, Yin-Ching
Lin, Jung-Chung
Lu, Po-Liang
author_sort Chang, Ya-Ting
collection PubMed
description PURPOSE: This study aimed to investigate the resistance mechanisms and molecular epidemiology of carbapenem-nonsusceptible Escherichia coli (CnsEC) in Taiwan. PATIENTS AND METHODS: From 2012 to 2015, 237 E. coli isolates with minimum inhibitory concentrations of imipenem or meropenem >1 μg/mL were collected in a nationwide surveillance and subjected to polymerase chain reaction (PCR) for carbapenemase, AmpC-type β-lactamase, and extended spectrum β-lactamase (ESBL) genes. We evaluated outer membrane proteins (OmpF and OmpC) loss and conducted multilocus sequence typing and pulsed-field gel electrophoresis (PFGE). Isolates that were resistant to all carbapenems were designated as pan-carbapenem-resistant E. coli (pCREC) in this study. RESULTS: The predominant resistance mechanism of CnsEC in Taiwan was the CMY-2 β-lactamase in combination with OmpF and OmpC loss. Sequence type 131 was the most prevalent type (29.2%). Among 237 CnsEC isolates, 106 (44.7%) isolates were pCREC and 18 (7.59%) produced carbapenemase. The prevalence of carbapenemases increased from 6% in 2012 to 11.36% in 2015. Various carbapenemases including KPC-2, IMP-8, NDM-1, NDM-5, VIM-1, OXA-48, and OXA-181 were identified, with NDM-1 being the most common (38.9%) carbapenemase. Comparison between pCREC and non-pCREC among the non-carbapenemase-producing CnsEC isolates revealed SHV, CMY, co-carriage of SHV and CTX-M and concurrent loss of both OmpF and OmpC were more commonly detected in the pCREC group. PFGE revealed no nationwide clonal spread of carbapenemase-producing E. coli. CONCLUSION: NDM-1 was the most common carbapenemase and combination of CMY-2 and concurrent OmpF and OmpC porin loss was the most prevalent resistance mechanism in CnsEC in Taiwan.
format Online
Article
Text
id pubmed-6642643
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-66426432019-08-12 Resistance mechanisms and molecular epidemiology of carbapenem-nonsusceptible Escherichia coli in Taiwan, 2012-2015 Chang, Ya-Ting Siu, L Kristopher Wang, Jann-Tay Wu, Tsu-Lan Chen, Yu-Hui Chuang, Yin-Ching Lin, Jung-Chung Lu, Po-Liang Infect Drug Resist Original Research PURPOSE: This study aimed to investigate the resistance mechanisms and molecular epidemiology of carbapenem-nonsusceptible Escherichia coli (CnsEC) in Taiwan. PATIENTS AND METHODS: From 2012 to 2015, 237 E. coli isolates with minimum inhibitory concentrations of imipenem or meropenem >1 μg/mL were collected in a nationwide surveillance and subjected to polymerase chain reaction (PCR) for carbapenemase, AmpC-type β-lactamase, and extended spectrum β-lactamase (ESBL) genes. We evaluated outer membrane proteins (OmpF and OmpC) loss and conducted multilocus sequence typing and pulsed-field gel electrophoresis (PFGE). Isolates that were resistant to all carbapenems were designated as pan-carbapenem-resistant E. coli (pCREC) in this study. RESULTS: The predominant resistance mechanism of CnsEC in Taiwan was the CMY-2 β-lactamase in combination with OmpF and OmpC loss. Sequence type 131 was the most prevalent type (29.2%). Among 237 CnsEC isolates, 106 (44.7%) isolates were pCREC and 18 (7.59%) produced carbapenemase. The prevalence of carbapenemases increased from 6% in 2012 to 11.36% in 2015. Various carbapenemases including KPC-2, IMP-8, NDM-1, NDM-5, VIM-1, OXA-48, and OXA-181 were identified, with NDM-1 being the most common (38.9%) carbapenemase. Comparison between pCREC and non-pCREC among the non-carbapenemase-producing CnsEC isolates revealed SHV, CMY, co-carriage of SHV and CTX-M and concurrent loss of both OmpF and OmpC were more commonly detected in the pCREC group. PFGE revealed no nationwide clonal spread of carbapenemase-producing E. coli. CONCLUSION: NDM-1 was the most common carbapenemase and combination of CMY-2 and concurrent OmpF and OmpC porin loss was the most prevalent resistance mechanism in CnsEC in Taiwan. Dove 2019-07-16 /pmc/articles/PMC6642643/ /pubmed/31406467 http://dx.doi.org/10.2147/IDR.S208231 Text en © 2019 Chang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Chang, Ya-Ting
Siu, L Kristopher
Wang, Jann-Tay
Wu, Tsu-Lan
Chen, Yu-Hui
Chuang, Yin-Ching
Lin, Jung-Chung
Lu, Po-Liang
Resistance mechanisms and molecular epidemiology of carbapenem-nonsusceptible Escherichia coli in Taiwan, 2012-2015
title Resistance mechanisms and molecular epidemiology of carbapenem-nonsusceptible Escherichia coli in Taiwan, 2012-2015
title_full Resistance mechanisms and molecular epidemiology of carbapenem-nonsusceptible Escherichia coli in Taiwan, 2012-2015
title_fullStr Resistance mechanisms and molecular epidemiology of carbapenem-nonsusceptible Escherichia coli in Taiwan, 2012-2015
title_full_unstemmed Resistance mechanisms and molecular epidemiology of carbapenem-nonsusceptible Escherichia coli in Taiwan, 2012-2015
title_short Resistance mechanisms and molecular epidemiology of carbapenem-nonsusceptible Escherichia coli in Taiwan, 2012-2015
title_sort resistance mechanisms and molecular epidemiology of carbapenem-nonsusceptible escherichia coli in taiwan, 2012-2015
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642643/
https://www.ncbi.nlm.nih.gov/pubmed/31406467
http://dx.doi.org/10.2147/IDR.S208231
work_keys_str_mv AT changyating resistancemechanismsandmolecularepidemiologyofcarbapenemnonsusceptibleescherichiacoliintaiwan20122015
AT siulkristopher resistancemechanismsandmolecularepidemiologyofcarbapenemnonsusceptibleescherichiacoliintaiwan20122015
AT wangjanntay resistancemechanismsandmolecularepidemiologyofcarbapenemnonsusceptibleescherichiacoliintaiwan20122015
AT wutsulan resistancemechanismsandmolecularepidemiologyofcarbapenemnonsusceptibleescherichiacoliintaiwan20122015
AT chenyuhui resistancemechanismsandmolecularepidemiologyofcarbapenemnonsusceptibleescherichiacoliintaiwan20122015
AT chuangyinching resistancemechanismsandmolecularepidemiologyofcarbapenemnonsusceptibleescherichiacoliintaiwan20122015
AT linjungchung resistancemechanismsandmolecularepidemiologyofcarbapenemnonsusceptibleescherichiacoliintaiwan20122015
AT lupoliang resistancemechanismsandmolecularepidemiologyofcarbapenemnonsusceptibleescherichiacoliintaiwan20122015